Related Experiment Video
Updated: Mar 7, 2026

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice
Published on: June 8, 2022
Low Level of Haptoglobin in Lupus
Homa Timlin1, Kirthi Machireddy2, Michelle Petri1
1Johns Hopkins University, Baltimore, MD, USA.
Low haptoglobin levels in lupus patients may not always indicate hemolysis. This study presents two cases of systemic lupus erythematosus with low haptoglobin without hemolysis, challenging typical interpretations.
Area of Science:
- Immunology
- Hematology
- Rheumatology
Background:
- Haptoglobin levels are routinely assessed in systemic lupus erythematosus (SLE) patients experiencing anemia.
- Low haptoglobin typically signifies hemolysis, a common complication in SLE.
- Haptoglobin functions as an acute phase reactant protein.
Purpose of the Study:
- To investigate the occurrence of low haptoglobin levels in SLE patients.
- To determine if low haptoglobin levels in SLE are exclusively indicative of hemolysis.
- To present case studies of SLE patients with unexplained low haptoglobin.
Main Methods:
- Review of clinical data for two systemic lupus erythematosus patients.
- Analysis of haptoglobin levels in conjunction with other hemolysis markers.
- Clinical assessment for evidence of hemolytic anemia.
Main Results:
- Two patients with systemic lupus erythematosus presented with low haptoglobin levels.
- No other laboratory or clinical evidence of hemolysis was found in these patients.
- This suggests low haptoglobin can occur in SLE without hemolysis.
Conclusions:
- Low haptoglobin levels in SLE patients should be interpreted cautiously.
- Further investigation may be needed to understand non-hemolytic causes of low haptoglobin in SLE.
- These findings highlight the complexity of interpreting hematological markers in autoimmune diseases.
More Related Videos
07:24A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy
07:29Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
Published on: October 12, 2017
Related Concept Videos
Rh Blood Group
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Humoral Immune Responses
Hypersensitivity Reactions: Cytolytic Reactions
Drug Distribution: Plasma Protein Binding